Repurposed molecules for antiepileptogenesis: Missing an opportunity to prevent epilepsy?

Author:

Klein Pavel1ORCID,Friedman Alon23,Hameed Mustafa Q.4,Kaminski Rafal M.5,Bar‐Klein Guy6,Klitgaard Henrik7,Koepp Mathias8,Jozwiak Sergiusz9,Prince David A.10,Rotenberg Alexander4,Twyman Roy11,Vezzani Annamaria12,Wong Michael13ORCID,Löscher Wolfgang1415ORCID

Affiliation:

1. Mid‐Atlantic Epilepsy and Sleep Center Bethesda Maryland

2. Departments of Physiology and Cell Biology, and Brain and Cognitive Science Zlotowski Center for Neuroscience Ben‐Gurion University of the Negev Beer‐Sheva Israel

3. Departments of Medical Neuroscience and Brain Repair Center Dalhousie University Halifax Canada

4. Neuromodulation Program Division of Epilepsy and Clinical Neurophysiology Department of Neurology Boston Children’s Hospital Harvard Medical School Boston Massachusetts

5. Neurosymptomatic Domains Section Roche Pharma Research & Early Development Roche Innovation Center Basel Switzerland

6. McKusick‐Nathans Institute of Genetic Medicine Howard Hughes Medical Institute Johns Hopkins University School of Medicine Baltimore Maryland

7. Neurosciences Therapeutic Area UCB Pharma Braine‐l’Alleud Belgium

8. Department of Clinical and Experimental Epilepsy University College London Institute of Neurology London UK

9. Department of Pediatric Neurology Warsaw Medical University Warsaw Poland

10. Neurology and the Neurological Sciences Stanford University School of Medicine Stanford California

11. Amron Neuroscience Darby, Montana

12. Department of Neuroscience Mario Negri Institute for Pharmacological Research, Scientific Institute for Research and Health Care Milan Italy

13. Department of Neurology Washington University School of Medicine St Louis Missouri

14. Department of Pharmacology, Toxicology, and Pharmacy University of Veterinary Medicine Hannover Germany

15. Center for Systems Neuroscience Hannover Germany

Publisher

Wiley

Subject

Clinical Neurology,Neurology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3